Table: Jcr Pharmaceuticals -2020/21 group results

JCR Pharmaceuticals

13/05/2021 08:00

May 13 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             30.09           24.78          49.00                 
                 (+21.4 pct)     (+7.0 pct)     (+62.9 pct)              
  Operating          8.27            3.24          18.70                 
                (+154.9 pct)     (-34.7 pct)   (+126.1 pct)              
  Recurring          8.49            3.29          18.70                 
                (+157.7 pct)     (-35.0 pct)   (+120.3 pct)              
  Net
  Net                6.89            2.68          13.30                 
                (+157.4 pct)     (-27.9 pct)    (+92.9 pct)              
  EPS             55.81 yen       21.72 yen     107.68 yen               
  EPS Diluted     55.53 yen       21.59 yen                              
  Ann Div                         32.00 yen      16.00 yen               
  -Q2 Div         18.00 yen       15.00 yen      8.00 yen                
  -Q4 Div         7.50 yen        17.00 yen      8.00 yen                
  
  NOTE - Jcr Pharmaceuticals Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T